Literature DB >> 16223530

Alterations in cell-mediated immune response in subacute sclerosing panencephalitis.

Sibel P Yentür1, Candan Gürses, Veysi Demirbilek, Gülden Yilmaz, Ayşe Emel Onal, Zuhal Yapici, Cengiz Yalçinkaya, Ozlem Cokar, Ayşen Gökyiğit, Güher Saruhan-Direskeneli.   

Abstract

To investigate T cell responses in subacute sclerosing panencephalitis (SSPE), we analyzed proliferation and cytokine secretion of cells from 35 patients and 42 healthy controls (HC) in response to central nervous system (CNS) antigens. The proliferation in response to myelin basic protein (MBP), myelin oligodendrocyte-glycoprotein (MOG) and alphaB-crystallin did not differ between groups. There was a trend towards a decrease in IL-12 production in response to MBP and in vitro IL-12 secretion of SSPE patients to measles virus vaccine (MVV) was lower than controls. Proliferation, as well as IFN-gamma, IL-12 and IL-10 production in response to purified protein derivate (PPD) was impaired in SSPE patients. The results did not demonstrate any by-stander cellular response against myelin antigens, implicating that CNS is not a predominant target of an autoimmune response in SSPE. The recall responses were lower in SSPE as reported in measles before.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223530     DOI: 10.1016/j.jneuroim.2005.09.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Nihal Olgac Dundar; Pinar Gencpinar; Nilgun Sallakci; Ozgur Duman; Senay Haspolat; Banu Anlar; Olcay Yegin
Journal:  J Neurovirol       Date:  2016-04-21       Impact factor: 2.643

2.  Subacute Sclerosing Panencephalitis in a Child with Human Immunodeficiency Virus Co-Infection.

Authors:  Pradeep Kumar Maurya; Mayur Deepak Thakkar; Dinkar Kulshreshtha; Ajai Kumar Singh; Anup Kumar Thacker
Journal:  Clin Med Res       Date:  2016-10-24

3.  Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Vuslat Yilmaz; Veysi Demirbilek; Candan Gürses; Sibel P Yentür; Serap Uysal; Zuhal Yapici; Gülden Yilmaz; Aaron Muncey; Ozlem Cokar; Emel Onal; Aysen Gökyiğit; Güher Saruhan-Direskeneli
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

4.  Adult-Onset Subacute Sclerosing Panencephalitis With a 30-Year Latent Period.

Authors:  Brandon B Holmes; Jessamyn Conell-Price; Collin J Kreple; Davin Ashraf; John Betjemann; Nicole Rosendale
Journal:  Neurohospitalist       Date:  2019-08-18

Review 5.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

6.  Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.

Authors:  Sibel P Yentür; Veysi Demirbilek; Candan Gurses; Safa Baris; Umit Kuru; Semih Ayta; Zuhal Yapici; Suzan Adin-Cinar; Serap Uysal; Gulden Celik Yilmaz; Emel Onal; Ozlem Cokar; Güher Saruhan-Direskeneli
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 7.  Subacute sclerosing panencephalitis in pregnancy.

Authors:  Michael H Chiu; Bonnie Meatherall; Ana Nikolic; Kristine Cannon; Kevin Fonseca; Jeffrey T Joseph; Judy MacDonald; Kanti Pabbaraju; Raymond Tellier; Sallene Wong; Marcus W Koch
Journal:  Lancet Infect Dis       Date:  2016-01-20       Impact factor: 25.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.